Biocept, Inc.
OTC: BIOCQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Soon Kap Hahn
- Employees
- 50
- Headquarters
- San Diego, United States
- IPO year
- 2014
- Market cap
- $525.0
- Website
- https://biocept.com
Loading BIOCQ…
Loading profile data…Frequently asked questions about BIOCQ
What does Biocept, Inc. (BIOCQ) do?
Biocept, Inc., established in 1997 and based in San Diego, California, was a molecular oncology diagnostics firm. Its primary business involved the development and commercialization of exclusive clinical laboratory assays within the United States. These advanced tests were engineered to detect elusive tumor cells and cell-free tumor DNA (ctDNA)...
Where does BIOCQ trade?
Biocept, Inc. (BIOCQ) trades on the Other OTC.
What sector is BIOCQ in?
Biocept, Inc. (BIOCQ) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Biocept, Inc.?
Soon Kap Hahn is the chief executive officer of Biocept, Inc. (BIOCQ).
Where is Biocept, Inc. headquartered?
Biocept, Inc. is headquartered in United States.
Does BIOCQ pay a dividend?
Biocept, Inc. (BIOCQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BIOCQ go public?
Biocept, Inc. (BIOCQ) completed its initial public offering in 2014.